HOCl expansion Leverage Sonoma's HOCl-based technologies and recent product launches (burn relief hydrogel, diaper rash, dermatology line) to cross-sell into acute care, pediatrics, dermatology clinics, and consumer retail channels.

Retail momentum Capitalize on nationwide U.S. retail activity with the burn relief hydrogel launch in CVS and Walmart, targeting hospital feeders, care facilities, and wound care wound clinics that preferentially stock HOCl-based solutions.

Global footprint Target international expansion opportunities by partnering with distributors in the UK and EU markets, aligning with the Aquanil line and Microcyn platform to accelerate dermatology and wound care adoption abroad.

Regulatory readiness Articulate the newly appointed SVP regulatory emphasis to streamline product registrations and faster time-to-market, enabling faster introductions of new HOCl products to retailers and clinics.

Clinical and vet synergies Explore cross-segment opportunities in veterinary, ophthalmology and podiatry where stabilized HOCl tech is applicable, expanding B2B channels with bundled solutions for multi-care settings.